• Username (E-mail)
  • Password
Dow 19,827 -0.3%  EStoxx50 3,285 -0.3%  Nikkei 18,814 -1.5%  EUR 1.0708 0.0% 
Nasdaq 5,539 -0.6%  FTSE100 7,220 -1.5%  Yen 112.6980 0.0%  Oil 55.5 -0.4% 
S&P500 2,268 -0.3%  DAX 11,540 -0.1%  GBP 1.2400 0.0%  Gold 1,216 0.0% 

Biomarin Pharmaceutical share [Symbol: BMRN / ISIN: US09061G1013]

Realtimequote Biomarin Pharmaceutical Inc. in USD

Exchange Market
85.25
Last
41,072
Volume
Time 03:59 PM
01/17/2017 03:59:47 PM UTC-0500
activate push

Stock Price Biomarin Pharmaceutical Inc. in USD

Activate push
85.21 USD -1.71 USD -1.97 %
Trade Time 5:20 PM Trade Date 1/17/2017
Daily High 86.34 Open 86.34
Daily Low 84.43 Prev. Close 85.21
52-week High 102.43 Volume (Qty.) 362,257
52-week Low 62.22 Market Cap (USD) 14.73 B
52-week Perf.
Exchange

Analyst Opinions for Biomarin Pharmaceutical Inc.

More Analyst Opinions
  • All
  • Buy
  • Hold
  • Sell
11/06/12
Biomarin Pharmaceutical RBC Capital Markets
09/03/12
Biomarin Pharmaceutical RBC Capital Markets
08/28/12
Biomarin Pharmaceutical Deutsche Bank Securities
07/23/12
Biomarin Pharmaceutical RBC Capital Markets
06/22/12
Biomarin Pharmaceutical RBC Capital Markets

Moody's Rating for Biomarin Pharmaceutical Inc.

Investment Grade (High Grade)
Investment Grade (Medium Grade)
Speculative Grade
Rating
Rating Update
Date of Rating
Rating Office -

Profile Biomarin Pharmaceutical Inc.

Company Profile
BioMarin Pharmaceutical, Inc. engages in the biopharmaceutical development and commercialization of innovative pharmaceuticals for serious diseases and medical conditions. Its company's products include Naglazyme, Kuvan, Aldurazyme, Firdapse and VIMIZIM. The company was founded on March 21, 1997 and is headquartered in Novato, CA.
pagehit

Add or Edit Instrument

Biomarin Pharmaceutical Chart - 1 Year - NAS
  • Intraday
  • 1w
  • 3 Mo.
  • 1y
  • 3y
  • 5y
  • Max
  • Exchange: NAS
  • Chart Options

Estimates for Biomarin Pharmaceutical

2015 2016e 2017e
Dividend - - -
Dividend Yield in % - - -
P/E Ratio -96.60 -23.17 -81.43
EPS -1.07 -3.71 -1.06

Biomarin Pharmaceutical Key Figures

Market Cap (USD) 14.73 B
Free Float in % 99.41
Number of Shares (Mio.) 171.99
Cash Flow per Share -1.96
Book Value per Share 8.30
60-Days Volatility 49.64
P/B Ratio 12.45

Base Data Biomarin Pharmaceutical

Symbol BMRN
ISIN US09061G1013
Indices NASDAQ Comp., NASDAQ 100

About the Company Biomarin Pharmaceutical

Country USA

Biomarin Pharmaceutical Historical Prices

01/12/2017
01/12/2017 06:00:00 PM UTC-0500
86.92 373,279
01/11/2017
01/11/2017 06:00:00 PM UTC-0500
86.16 412,536
01/10/2017
01/10/2017 06:00:00 PM UTC-0500
86.07 697,078
01/09/2017
01/09/2017 06:00:00 PM UTC-0500
90.40 414,927
01/08/2017
01/08/2017 06:00:00 PM UTC-0500
91.03 690,901

Biomarin Pharmaceutical Peer Group

Similar shares with higher 1-year perf.